Hepatic steatosis in patients with acromegaly.
Andreani Koutsou-TassopoulouIfigeneia Papapostoli-SklavounouMarcin KrawczykBettina Friesenhahn-OchsSusanne N WeberFrank LammertCaroline S StokesPublished in: Endocrinology, diabetes & metabolism (2019)
This study shows that in patients with acromegaly, carriers of the PNPLA3 susceptibility allele are at risk of developing hepatic steatosis, as assessed by CAP. Comorbid NAFLD might compound prognosis in such patients; thus, further research into the pathomechanisms and treatment of NAFLD in acromegaly is warranted.